Affiliation:
1. Faculty of Chemistry University of Warsaw 1 Pasteur St. 02-093 Warsaw Poland
2. Division of Biophysics Institute of Experimental Physics Faculty of Physics University of Warsaw 02-089 Warsaw Poland
3. Nencki Institute of Experimental Biology 3 Pasteur Street 02-093 Warsaw Poland
Abstract
AbstractAryloxy triester phosphoramidate methodology, commonly known as ProTide technology, is one of the most widely used prodrug approaches applied to therapeutic nucleosides. This approach has been used extensively by the pharmaceutical industry and researchers in medicinal chemistry. Herein we report our adaptation of this effective method for the synthesis of bioactive 5’‐mRNA cap analogues as inhibitors for targeting cap‐dependent translation. The synthesis was performed in two main stages: preparation of N2‐modified guanosine analogues and their subsequent transformation into prodrugs using phenylethoxy‐l‐alaninyl phosphorochloridate. The prepared pro‐nucleotide cap analogues were tested for their capacity in enzymatic activation, inhibitory properties in a rabbit reticulocyte lysate system, and passive membrane translocation properties.
Subject
Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献